Fresenius Medical Care AG & Co. (FMS)
| Market Cap | 17.70B |
| Revenue (ttm) | 17.96B |
| Net Income (ttm) | 877.72M |
| Shares Out | 586.06M |
| EPS (ttm) | 1.58 |
| PE Ratio | 19.09 |
| Forward PE | 14.03 |
| Dividend | $0.49 (1.63%) |
| Ex-Dividend Date | May 13, 2022 |
| Volume | 686,998 |
| Open | 29.89 |
| Previous Close | 30.11 |
| Day's Range | 29.87 - 30.37 |
| 52-Week Range | 28.75 - 42.45 |
| Beta | 0.94 |
| Analysts | Hold |
| Price Target | 34.13 (+13.0%) |
| Earnings Date | May 5, 2022 |
About FMS
Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage rena...
Financial Performance
In 2021, FMS's revenue was $17.62 billion, a decrease of -1.35% compared to the previous year's $17.86 billion. Earnings were $969.31 million, a decrease of -16.75%.
Financial StatementsAnalyst Forecast
According to 28 analysts, the average rating for FMS stock is "Hold." The 12-month stock price forecast is 34.13, which is an increase of 13.01% from the latest price.
News
Fresenius Medical Care Celebrates Diversity and Unity of a Global Nurse Workforce
HONG KONG--(BUSINESS WIRE)-- #healthcare--Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today announced its global ‘United in Care' c...
Fresenius Medical (FMS) Q1 Earnings & Revenues Top Estimates
Fresenius Medical's (FMS) first-quarter earnings benefit from strong performance across all the geographic regions and segments.
Fresenius Medical (FMS) Launches Campaign to Boost Kidney Care
Fresenius Medical's (FMS) My Reason campaign will help scientists understand genetic variations in patients with chronic kidney disease in a better way.
Fresenius Medical Care Launches My Reason® Campaign to Enroll Patients in Groundbreaking Renal-focused Genomic Registry
Goal of 100,000 Participants Within Five Years to Help Scientists Better Understand Genetic Variations in Patients with Chronic Kidney Disease WALTHAM, Mass. , April 13, 2022 /PRNewswire/ -- Fresenius M...
Fresenius Medical Care Appoints Dr. Amaka Eneanya as Head of Strategy and Operations for Company's Global Medical Office
WALTHAM, Mass. , April 5, 2022 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, announced today the appointment of noted...
Fresenius Medical's (FMS) Merger Deal to Improve Kidney Care
Fresenius Medical's (FMS) merger deal to build an independent entity to transform kidney care and health equity throughout the United States.
How Fresenius Medical Care's Superhero Is Helping Bridge the Knowledge Gap to Better Kidney Health
HONG KONG--(BUSINESS WIRE)-- #chronickidneydisease--Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, has today announced the social medi...
Fresenius Medical (FMS) Q4 Earnings Beat Estimates, Up Y/Y
Fresenius Medical's (FMS) fourth-quarter earnings benefit from strong performance across all the geographic regions and segments.
Fresenius's Q4 Operating Income Hit By COVID-19 Related Headwinds, Targets Earnings Growth In FY22
Fresenius Medical Care AG & Co's (NYSE: FMS) Q4 net income increased 29% Y/Y to €229 million, while quarterly net income was up 23% at constant currency. Adjusted net income for Q4 declined by 29% to €...
Fresenius Medical Care Asia Pacific Receives Prestigious ACHS Global Quality Improvement Award
HONG KONG--(BUSINESS WIRE)-- #chronickidneydisease--Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, was presented with the prestigious ...
Fresenius Medical Care launches new mobile app to empower and engage nurses
HONG KONG--(BUSINESS WIRE)-- #clinic--Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today announced the launch of Carrie, a custom-bu...
Fresenius Medical's (FMS) New Dialyzer to Boost Patient Outcome
Fresenius Medical's (FMS) latest dialyzer is expected to better serve dialysis patients because of its design.
Fresenius Medical Care Unveils Intelligent Home Dialysis Solutions at China International Import Expo (CIIE)
HONG KONG--(BUSINESS WIRE)-- #china--Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, today presented its advances in home dialysis solu...
Fresenius Medical (FMS) Q3 Earnings Beat Estimates, Down Y/Y
Fresenius Medical's (FMS) third-quarter earnings benefit from strong performance across the regions, Asia Pacific and Latin America.
Generation Income Properties Announces Agreement for Pending $3.1 Million Transaction
TAMPA, FL / ACCESSWIRE / November 1, 2021 / Generation Income Properties, Inc. (NASDAQ:GIPR) ("GIP" or the "Company") announced the signing of a definitive Purchase and Sale Agreement under which the Co...
New Strong Sell Stocks for October 14th
ARNC, BSET, FMS, OCUL, and PTGX have been added to the Zacks Rank #5 (Strong Sell) List on October 14, 2021.
Ominous Death Cross Forms On Fresenius Medical Care's Chart
If history is any guide, there may be trouble ahead for shares of Fresenius Medical Care(NYSE:FMS). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the...
Fresenius Medical's (FMS) Deal to Boost Home Dialysis in Japan
Fresenius Medical (FMS) partners with JMS Co. Ltd. to provide innovative home dialysis therapies to the aging population in Japan to improve their wellbeing.
Fresenius Medical Care Partners with JMS Co. Ltd. to Advance Home Dialysis Treatment in Japan
HONG KONG--(BUSINESS WIRE)-- #Japan--Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, has today announced a strategic distribution partn...
Fresenius Medical (FMS) Q2 Earnings Beat Estimates, Up Y/Y
Fresenius Medical's (FMS) second-quarter earnings benefit from strong performance across the regions, EMEA, Asia Pacific and Latin America.
Recap: Fresenius Medical Care Q2 Earnings
Shares of Fresenius Medical Care (NYSE:FMS) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share were down 31.82% over the past year to $0.45, which missed the esti...
15 European Dividend Aristocrats to Diversify Your Portfolio
Plenty of investors focus in on dividends, and dividend aristocrats, but if those investors only look in the U.S. they could be missing out. The post 15 European Dividend Aristocrats to Diversify Your P...
Fresenius Medical's (FMS) Xenios Gets NMPA Nod for ECMO System
Fresenius Medical (FMS) company receives expedited approval from NMPA permitting the Xenios AG's console and patient kits for ECMO therapy in China.
Fresenius Medical's (FMS) Training Center to Boost Patient Care
Fresenius Medical (FMS) inaugurates new training center in Korea to help in the improvement of patient care by offering comprehensive education programs for healthcare professionals.
Fresenius Medical Care Supports Education for Healthcare Professionals in Korea With the Opening of Its First Trainin...
HONG KONG--(BUSINESS WIRE)-- #chronickidneydisease--Fresenius Medical Care, the world's leading provider of products and services for individuals with renal diseases, recently announced the grand openin...